Clinical Trials Directory

Trials / Completed

CompletedNCT02158442

Technology That Permits Focal Dose of Antibiotics to be Delivered to Lower Limb(s) of Diabetic Patients

Randomized Study Comparing Clinical and Microbiological Efficacy of Timentin Delivered Via Percutaneous Isolated Limb Perfusion (PILP) or Intravenous Infusion in Diabetic Subjects With Moderate to Severe Lower Limb Infection

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Osprey Medical, Inc · Industry
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The use of the Percutaneous Isolated Limb Procedure (PILP) which enables the use of existing antibiotic therapies in a more targeted and concentrated fashion in patients with diabetes who have a significant lower limb infection and it is deemed that IV antibiotics are needed in order to salvage the limb or life.

Detailed description

During the PILP procedure, the circulation of the limb is isolated separately from the general circulatory system thereby enabling the delivery of antibiotics only to the limb. Limb isolation is achieved by creating an "artificial" circuit where catheters are inserted into the major artery and vein of the lower limb.

Conditions

Interventions

TypeNameDescription
PROCEDUREPercutaneous Isolated Limb Perfusion (PILP) deliveryThe Percutaneous Isolated Limb Perfusion (PILP) delivery intervention procedure enables the use of existing antibiotic therapies in a more targeted and aggressive fashion; it addresses limitations associated with the use of conventional antibiotic drug delivery. As part of the procedure, the circulation of the limb is isolated separately from the general circulatory system enabling the delivery of antibiotic at high therapeutic doses that are not achievable when standard doses are administered intravenously.
DRUGTimentinThe Control Group will receive standard dosings of intravenous Timentin plus other standard care.

Timeline

Start date
2013-10-01
Primary completion
2015-02-01
Completion
2015-03-01
First posted
2014-06-06
Last updated
2016-09-30
Results posted
2016-08-03

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT02158442. Inclusion in this directory is not an endorsement.

Technology That Permits Focal Dose of Antibiotics to be Delivered to Lower Limb(s) of Diabetic Patients (NCT02158442) · Clinical Trials Directory